Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Clementi

Showing results (241-250 of 281) with videos related to

Pageof 29
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 7, 2026
Refining free fatty acid receptor agonism for metabolic control: Pharmacological and functional features of novel dual GPR40/GPR120 ligandsKashi Brunetti, Bruno Fassari, Elisabetta Catalani, et al.
Human Mutation|May 12, 2009
A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological functionChiara Vantaggiato, Francesca Redaelli, Sestina Falcone, et al.
Cellular and Molecular Life Sciences : CMLS|August 5, 2020
Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagyElisabetta Catalani, Silvia Bongiorni, Anna Rita Taddei, et al.
Cells|April 5, 2020
Acid Sphingomyelinase Downregulation Enhances Mitochondrial Fusion and Promotes Oxidative Metabolism in a Mouse Model of MelanomaMarco Coazzoli, Alessandra Napoli, Paulina Roux-Biejat, et al.
The Pharmacogenomics Journal|March 2, 2021
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patientsSara Demurtas, Nicla La Verde, Selene Rota, et al.
Pharmacological Research|July 1, 2021
Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular DystrophyMatteo Giovarelli, Silvia Zecchini, Giorgia Catarinella, et al.
Journal of Clinical Medicine|December 9, 2023
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 StudyAnna Bombelli, Greta Guarnieri, Niccolò Lombardi, et al.
Expert Opinion on Drug Safety|November 24, 2016
A retrospective review of paediatric adverse drug reactions reported in Lombardy and Croatia from 2005 to 2013Carla Carnovale, Marta Gentili, Marco Matacena, et al.
Pharmacological Research|February 7, 2012
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patientsMaria Grazia D'Angelo, Sandra Gandossini, Filippo Martinelli Boneschi, et al.
International Journal of Molecular Sciences|May 7, 2025
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic CohortMarco Schiuma, Sofia Dinegro, Vera Battini, et al.
Pageof 29

Showing results (241-250 of 281) with videos related to

Sort By:
Pageof 29
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 7, 2026
Refining free fatty acid receptor agonism for metabolic control: Pharmacological and functional features of novel dual GPR40/GPR120 ligandsKashi Brunetti, Bruno Fassari, Elisabetta Catalani, et al.
Human Mutation|May 12, 2009
A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological functionChiara Vantaggiato, Francesca Redaelli, Sestina Falcone, et al.
Cellular and Molecular Life Sciences : CMLS|August 5, 2020
Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagyElisabetta Catalani, Silvia Bongiorni, Anna Rita Taddei, et al.
Cells|April 5, 2020
Acid Sphingomyelinase Downregulation Enhances Mitochondrial Fusion and Promotes Oxidative Metabolism in a Mouse Model of MelanomaMarco Coazzoli, Alessandra Napoli, Paulina Roux-Biejat, et al.
The Pharmacogenomics Journal|March 2, 2021
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patientsSara Demurtas, Nicla La Verde, Selene Rota, et al.
Pharmacological Research|July 1, 2021
Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular DystrophyMatteo Giovarelli, Silvia Zecchini, Giorgia Catarinella, et al.
Journal of Clinical Medicine|December 9, 2023
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 StudyAnna Bombelli, Greta Guarnieri, Niccolò Lombardi, et al.
Expert Opinion on Drug Safety|November 24, 2016
A retrospective review of paediatric adverse drug reactions reported in Lombardy and Croatia from 2005 to 2013Carla Carnovale, Marta Gentili, Marco Matacena, et al.
Pharmacological Research|February 7, 2012
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patientsMaria Grazia D'Angelo, Sandra Gandossini, Filippo Martinelli Boneschi, et al.
International Journal of Molecular Sciences|May 7, 2025
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic CohortMarco Schiuma, Sofia Dinegro, Vera Battini, et al.
Pageof 29